Refractory idiopathic multicentric Castleman disease responsive to sirolimus therapy

被引:4
作者
Bayram, Ertugrul [1 ]
Pehlivan, Umur Anil [2 ]
Fajgenbaum, David C. [3 ]
Paydas, Semra [1 ,4 ]
机构
[1] Cukurova Univ, Fac Med, Dept Med Oncol, Adana, Turkey
[2] Baskent Univ Adana Dr Turgut Noyan Applicat, Res Ctr Dept Radiol, Dept Radiol, Adana, Turkey
[3] Univ Penn, Perelman Sch Med, Ctr Cytokine Storm Treatment & Lab, Div Translat Med & Human Genet, Philadelphia, PA USA
[4] Cukurova Univ, Fac Med, Dept Med Oncol, TR-01380 Adana, Turkey
关键词
D O I
10.1002/ajh.26783
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:361 / 364
页数:4
相关论文
共 18 条
[1]   Treatment of multicentric Castleman disease through combination of tocilizumab, lenalidomide and glucocorticoids Case report [J].
Cai, Sisi ;
Zhong, Zhaodong ;
Li, Xiang ;
Wang, Hong Xiang ;
Wang, Li ;
Zhang, Min .
MEDICINE, 2019, 98 (46) :e17681
[2]   Overview of Castleman disease [J].
Dispenzieri, Angela ;
Fajgenbaum, David C. .
BLOOD, 2020, 135 (16) :1353-1364
[3]   Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6 blockade-refractory idiopathic multicentric Castleman disease [J].
Fajgenbaum, David C. ;
Langan, Ruth-Anne ;
Japp, Alberto Sada ;
Partridge, Helen L. ;
Pierson, Sheila K. ;
Singh, Amrit ;
Arenas, Daniel J. ;
Ruth, Jason R. ;
Nabel, Christopher S. ;
Stone, Katie ;
Okumura, Mariko ;
Schwarer, Anthony ;
Jose, Fabio Freire ;
Hamerschlak, Nelson ;
Wertheim, Gerald B. ;
Jordan, Michael B. ;
Cohen, Adam D. ;
Krymskaya, Vera ;
Rubenstein, Arthur ;
Betts, Michael R. ;
Kambayashi, Taku ;
van Rhee, Frits ;
Uldrick, Thomas S. .
JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (10) :4451-4463
[4]   International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease [J].
Fajgenbaum, David C. ;
Uldrick, Thomas S. ;
Bagg, Adam ;
Frank, Dale ;
Wu, David ;
Srkalovic, Gordan ;
Simpson, David ;
Liu, Amy Y. ;
Menke, David ;
Chandrakasan, Shanmuganathan ;
Lechowicz, Mary Jo ;
Wong, Raymond S. M. ;
Pierson, Sheila ;
Paessler, Michele ;
Rossi, Jean-Francois ;
Ide, Makoto ;
Ruth, Jason ;
Croglio, Michael ;
Suarez, Alexander ;
Krymskaya, Vera ;
Chadburn, Amy ;
Colleoni, Gisele ;
Nasta, Sunita ;
Jayanthan, Raj ;
Nabel, Christopher S. ;
Casper, Corey ;
Dispenzieri, Angela ;
Fossa, Alexander ;
Kelleher, Dermot ;
Kurzrock, Razelle ;
Voorhees, Peter ;
Dogan, Ahmet ;
Yoshizaki, Kazuyuki ;
van Rhee, Frits ;
Oksenhendler, Eric ;
Jaffe, Elaine S. ;
Elenitoba-Johnson, Kojo S. J. ;
Lim, Megan S. .
BLOOD, 2017, 129 (12) :1646-1657
[5]   Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease? [J].
Fujimoto, Shino ;
Sakai, Tomoyuki ;
Kawabata, Hiroshi ;
Kurose, Nozomu ;
Yamada, Sohsuke ;
Takai, Kazue ;
Aoki, Sadao ;
Kuroda, Junya ;
Ide, Makoto ;
Setoguchi, Keigo ;
Tsukamoto, Norifumi ;
Iwao-Kawanami, Haruka ;
Kawanami, Takafumi ;
Mizuta, Shuichi ;
Fukushima, Toshihiro ;
Masaki, Yasufumi .
AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (09) :975-983
[6]  
Garcia KM., 2018, CANC THER ONCOL INT, V9
[7]  
Garcia KM., 2018, CANC THER ONCOL INT, V9, P135
[8]   Elevated serum interferon γ-induced protein 10 kDa is associated with TAFRO syndrome [J].
Iwaki, Noriko ;
Gion, Yuka ;
Kondo, Eisei ;
Kawano, Mitsuhiro ;
Masunari, Taro ;
Moro, Hiroshi ;
Nikkuni, Koji ;
Takai, Kazue ;
Hagihara, Masao ;
Hashimoto, Yuko ;
Yokota, Kenji ;
Okamoto, Masataka ;
Nakao, Shinji ;
Yoshino, Tadashi ;
Sato, Yasuharu .
SCIENTIFIC REPORTS, 2017, 7
[9]  
KELLER AR, 1972, CANCER-AM CANCER SOC, V29, P670, DOI 10.1002/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO
[10]  
2-#